REPORT ID 15879

Asia-Pacific Metabolism Drugs Market Report 2017

Publish Date
30-Nov-17
Pages
106
Format
Electronic (PDF)

In this report, the Asia-Pacific Metabolism Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Metabolism Drugs for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Metabolism Drugs market competition by top manufacturers/players, with Metabolism Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck
    Novartis
    Takeda Pharmaceutical
    Astra Zeneca
    Beohrigher Ingelheim
    KOWA
    Kythera
    Fuji yakuhin
    LG Life Science
    Metsubishi Tanabe Pharma

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Glycogen Metabolism Disease Drug
    Lipid Metabolism Disease Drug
    Amino Acid Metabolism Drug
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Metabolism Drugs for each application, includin
    Hospital
    Retail Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Metabolism Drugs Market Report 2017
1 Metabolism Drugs Overview
    1.1 Product Overview and Scope of Metabolism Drugs
    1.2 Classification of Metabolism Drugs by Product Category
        1.2.1 Asia-Pacific Metabolism Drugs Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Metabolism Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Glycogen Metabolism Disease Drug
        1.2.4 Lipid Metabolism Disease Drug
        1.2.5 Amino Acid Metabolism Drug
        1.2.6 Other
    1.3 Asia-Pacific Metabolism Drugs Market by Application/End Users
        1.3.1 Asia-Pacific Metabolism Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Asia-Pacific Metabolism Drugs Market by Region
        1.4.1 Asia-Pacific Metabolism Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Metabolism Drugs (2012-2022)
        1.5.1 Asia-Pacific Metabolism Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Metabolism Drugs Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Metabolism Drugs Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Metabolism Drugs Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Metabolism Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Metabolism Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Metabolism Drugs (Volume and Value) by Type
        2.2.1 Asia-Pacific Metabolism Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Metabolism Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Metabolism Drugs (Volume) by Application
    2.4 Asia-Pacific Metabolism Drugs (Volume and Value) by Region
        2.4.1 Asia-Pacific Metabolism Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Metabolism Drugs Revenue and Market Share by Region (2012-2017)

3 China Metabolism Drugs (Volume, Value and Sales Price)
    3.1 China Metabolism Drugs Sales and Value (2012-2017)
        3.1.1 China Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Metabolism Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 China Metabolism Drugs Sales Price Trend (2012-2017)
    3.2 China Metabolism Drugs Sales Volume and Market Share by Type
    3.3 China Metabolism Drugs Sales Volume and Market Share by Application

4 Japan Metabolism Drugs (Volume, Value and Sales Price)
    4.1 Japan Metabolism Drugs Sales and Value (2012-2017)
        4.1.1 Japan Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Metabolism Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Metabolism Drugs Sales Price Trend (2012-2017)
    4.2 Japan Metabolism Drugs Sales Volume and Market Share by Type
    4.3 Japan Metabolism Drugs Sales Volume and Market Share by Application

5 South Korea Metabolism Drugs (Volume, Value and Sales Price)
    5.1 South Korea Metabolism Drugs Sales and Value (2012-2017)
        5.1.1 South Korea Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Metabolism Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Metabolism Drugs Sales Price Trend (2012-2017)
    5.2 South Korea Metabolism Drugs Sales Volume and Market Share by Type
    5.3 South Korea Metabolism Drugs Sales Volume and Market Share by Application

6 Taiwan Metabolism Drugs (Volume, Value and Sales Price)
    6.1 Taiwan Metabolism Drugs Sales and Value (2012-2017)
        6.1.1 Taiwan Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Metabolism Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Metabolism Drugs Sales Price Trend (2012-2017)
    6.2 Taiwan Metabolism Drugs Sales Volume and Market Share by Type
    6.3 Taiwan Metabolism Drugs Sales Volume and Market Share by Application

7 India Metabolism Drugs (Volume, Value and Sales Price)
    7.1 India Metabolism Drugs Sales and Value (2012-2017)
        7.1.1 India Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Metabolism Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 India Metabolism Drugs Sales Price Trend (2012-2017)
    7.2 India Metabolism Drugs Sales Volume and Market Share by Type
    7.3 India Metabolism Drugs Sales Volume and Market Share by Application

8 Southeast Asia Metabolism Drugs (Volume, Value and Sales Price)
    8.1 Southeast Asia Metabolism Drugs Sales and Value (2012-2017)
        8.1.1 Southeast Asia Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Metabolism Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Metabolism Drugs Sales Price Trend (2012-2017)
    8.2 Southeast Asia Metabolism Drugs Sales Volume and Market Share by Type
    8.3 Southeast Asia Metabolism Drugs Sales Volume and Market Share by Application

9 Australia Metabolism Drugs (Volume, Value and Sales Price)
    9.1 Australia Metabolism Drugs Sales and Value (2012-2017)
        9.1.1 Australia Metabolism Drugs Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Metabolism Drugs Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Metabolism Drugs Sales Price Trend (2012-2017)
    9.2 Australia Metabolism Drugs Sales Volume and Market Share by Type
    9.3 Australia Metabolism Drugs Sales Volume and Market Share by Application

10 Asia-Pacific Metabolism Drugs Players/Suppliers Profiles and Sales Data
    10.1 Merck
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Metabolism Drugs Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Merck Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Novartis
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Metabolism Drugs Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Novartis Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Takeda Pharmaceutical
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Metabolism Drugs Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Takeda Pharmaceutical Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Astra Zeneca
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Metabolism Drugs Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Astra Zeneca Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Beohrigher Ingelheim
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Metabolism Drugs Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Beohrigher Ingelheim Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 KOWA
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Metabolism Drugs Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 KOWA Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Kythera
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Metabolism Drugs Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Kythera Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Fuji yakuhin
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Metabolism Drugs Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 LG Life Science
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Metabolism Drugs Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Metsubishi Tanabe Pharma
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Metabolism Drugs Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview

11 Metabolism Drugs Manufacturing Cost Analysis
    11.1 Metabolism Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Metabolism Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Metabolism Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Metabolism Drugs Market Forecast (2017-2022)
    15.1 Asia-Pacific Metabolism Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Metabolism Drugs Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Metabolism Drugs Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Metabolism Drugs Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Metabolism Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Metabolism Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Metabolism Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Metabolism Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Metabolism Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Metabolism Drugs Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Metabolism Drugs Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Metabolism Drugs Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Metabolism Drugs Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer